Table 1.

Clinicopathological features

Parameters	Normal	Stage I	Stage II	Stage III	Stage IV
Number of cases	11	14	15	15	10
Age (years) (mean ± SEM)	40 ± 2.6	48 ± 2	53 ± 3	43 ± 2.6	55 ± 3.5
Menopausal status
Pre	84	84.6	55.5	73	62.5
Post	16	15.4	44.5	27	37.5
Type
IDC	NA	100	93	87.5	100
ILC	NA	0	7	12.5	0
Hormone status
ER Positive	NA	77	53	80	62.5
PR Positive	NA	54	44	80	50
Her2/neu positive	NA	23	37.5	53	37.5
p53 positive	NA	70	30	33	33

All values except number of cases and age represent N (%)

NA not applicable, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, ER estrogen receptor, PR progesterone receptor, Her2/neu human epidermal growth factor receptor 2